JP2013533232A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013533232A5 JP2013533232A5 JP2013514194A JP2013514194A JP2013533232A5 JP 2013533232 A5 JP2013533232 A5 JP 2013533232A5 JP 2013514194 A JP2013514194 A JP 2013514194A JP 2013514194 A JP2013514194 A JP 2013514194A JP 2013533232 A5 JP2013533232 A5 JP 2013533232A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cancer
- composition according
- agent
- taxane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35233310P | 2010-06-07 | 2010-06-07 | |
| US61/352,333 | 2010-06-07 | ||
| US201161446909P | 2011-02-25 | 2011-02-25 | |
| US61/446,909 | 2011-02-25 | ||
| PCT/US2011/037450 WO2011156119A1 (en) | 2010-06-07 | 2011-05-20 | Combination therapy methods for treating proliferative diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016132221A Division JP2016175947A (ja) | 2010-06-07 | 2016-07-04 | 増殖性疾患を処置するための組み合わせ療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013533232A JP2013533232A (ja) | 2013-08-22 |
| JP2013533232A5 true JP2013533232A5 (https=) | 2014-07-03 |
| JP6031437B2 JP6031437B2 (ja) | 2016-11-24 |
Family
ID=45098373
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013514194A Active JP6031437B2 (ja) | 2010-06-07 | 2011-05-20 | 増殖性疾患を処置するための組み合わせ療法 |
| JP2016132221A Withdrawn JP2016175947A (ja) | 2010-06-07 | 2016-07-04 | 増殖性疾患を処置するための組み合わせ療法 |
| JP2018025928A Pending JP2018087227A (ja) | 2010-06-07 | 2018-02-16 | 増殖性疾患を処置するための組み合わせ療法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016132221A Withdrawn JP2016175947A (ja) | 2010-06-07 | 2016-07-04 | 増殖性疾患を処置するための組み合わせ療法 |
| JP2018025928A Pending JP2018087227A (ja) | 2010-06-07 | 2018-02-16 | 増殖性疾患を処置するための組み合わせ療法 |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US20140155344A1 (https=) |
| EP (2) | EP2575774A4 (https=) |
| JP (3) | JP6031437B2 (https=) |
| KR (1) | KR101850566B1 (https=) |
| CN (2) | CN103037846B (https=) |
| AU (2) | AU2011264590B2 (https=) |
| BR (1) | BR112012031163A2 (https=) |
| CA (1) | CA2801891C (https=) |
| CO (1) | CO6670568A2 (https=) |
| CR (1) | CR20120638A (https=) |
| IL (2) | IL223190A0 (https=) |
| MX (1) | MX2012014231A (https=) |
| MY (1) | MY166014A (https=) |
| NI (1) | NI201200181A (https=) |
| NZ (1) | NZ707377A (https=) |
| PH (1) | PH12012502399A1 (https=) |
| RU (2) | RU2577278C2 (https=) |
| SG (2) | SG10201504590WA (https=) |
| WO (1) | WO2011156119A1 (https=) |
| ZA (1) | ZA201208820B (https=) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| CN103405405A (zh) | 2002-12-09 | 2013-11-27 | 阿布拉西斯生物科学有限责任公司 | 组合物和传递药剂的方法 |
| SI1853250T1 (sl) | 2005-02-18 | 2012-01-31 | Abraxis Bioscience Llc | Kombinacije in reĹľimi dajanja terapevtskih sredstev in kombinirana terapija |
| US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| KR101420445B1 (ko) | 2005-08-31 | 2014-07-16 | 아브락시스 바이오사이언스, 엘엘씨 | 수 난용성 제약학적 약제 및 항균제를 포함하는 조성물 |
| EP3470071A1 (en) | 2006-12-14 | 2019-04-17 | Abraxis BioScience, LLC | Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| JP5579057B2 (ja) * | 2007-06-01 | 2014-08-27 | アブラクシス バイオサイエンス， エルエルシー | 再発性癌の処置のための方法および組成物 |
| HRP20192259T1 (hr) | 2009-04-15 | 2020-03-06 | Abraxis Bioscience, Llc | Pripravci nanočestica bez priona i metode njihove proizvodnje |
| CA3051495A1 (en) | 2010-03-26 | 2011-09-29 | Abraxis Bioscience, Llc | Use of nanoparticles comprising a taxane and albumin in the treatment of hepatocellular carcinoma |
| KR20130028727A (ko) | 2010-03-29 | 2013-03-19 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 약물 전달 및 유효성 향상 방법 |
| NZ717490A (en) | 2010-03-29 | 2017-12-22 | Abraxis Bioscience Llc | Methods of treating cancer |
| BR112012030909A2 (pt) | 2010-06-04 | 2020-08-18 | Abraxis Bioscience, Llc | métodos de tratamento de câncer pancreático |
| WO2011156119A1 (en) * | 2010-06-07 | 2011-12-15 | Abraxis Bioscience, Llc | Combination therapy methods for treating proliferative diseases |
| JP6038123B2 (ja) | 2011-04-28 | 2016-12-07 | アブラクシス バイオサイエンス， エルエルシー | ナノ粒子組成物の脈管内送達およびそれらの使用 |
| KR20140041505A (ko) | 2011-04-29 | 2014-04-04 | 셀렉타 바이오사이언시즈, 인크. | 조절 b 세포 유도를 위한 관용원성 합성 나노운반체 |
| PT2707030T (pt) | 2011-05-09 | 2020-05-22 | Mayo Found Medical Education & Res | Tratamentos de cancro |
| US9125884B2 (en) | 2011-11-01 | 2015-09-08 | Celgene Corporation | Methods for treating cancers using oral formulations of cytidine analogs |
| JP6216721B2 (ja) | 2011-12-14 | 2017-10-18 | アブラクシス バイオサイエンス， エルエルシー | 粒子を凍結乾燥または凍結するためのポリマー賦形剤の使用 |
| US10413606B2 (en) | 2012-10-01 | 2019-09-17 | Mayo Foundation For Medical Education And Research | Methods for treating cancer with nanoparticle complexes of albumin-bound paclitaxel and anti-VEGF antibodies |
| US9149455B2 (en) | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
| US9511046B2 (en) | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
| EP3698784A1 (en) | 2013-03-12 | 2020-08-26 | Abraxis BioScience, LLC | Methods of treating lung cancer |
| EP2968191B1 (en) | 2013-03-14 | 2021-06-16 | Abraxis BioScience, LLC | Methods of treating bladder cancer |
| WO2014179771A1 (en) * | 2013-05-03 | 2014-11-06 | Selecta Biosciences, Inc. | Dosing combinations for reducing undesired humoral immune responses |
| HUE052599T2 (hu) * | 2013-05-03 | 2021-05-28 | Selecta Biosciences Inc | CD4+ szabályozó T-sejtek fokozására szolgáló eljárások és készítmények |
| US20160250351A1 (en) | 2014-06-13 | 2016-09-01 | Mayo Foundation For Medical Education And Research | Treating Lymphomas |
| EP3834889A1 (en) | 2014-06-16 | 2021-06-16 | Mayo Foundation for Medical Education and Research | Treating myelomas |
| WO2015195634A1 (en) * | 2014-06-17 | 2015-12-23 | Celgne Corporation | Methods for treating epstein-barr virus (ebv) associated cancers using oral formulations of 5-azacytidine |
| AU2015311704B2 (en) | 2014-09-07 | 2021-12-09 | Selecta Biosciences, Inc. | Methods and compositions for attenuating gene editing anti-viral transfer vector immune responses |
| US9446148B2 (en) | 2014-10-06 | 2016-09-20 | Mayo Foundation For Medical Education And Research | Carrier-antibody compositions and methods of making and using the same |
| WO2016089873A1 (en) * | 2014-12-02 | 2016-06-09 | Celgene Corporation | Combination therapies |
| US10527604B1 (en) | 2015-03-05 | 2020-01-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel |
| US10705070B1 (en) | 2015-03-05 | 2020-07-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug |
| PL3998069T3 (pl) | 2015-06-29 | 2025-03-31 | Abraxis Bioscience, Llc | Nanocząsteczki zawierające syrolimus i albuminę do zastosowania w leczeniu nowotworów z komórek nabłonkowatych |
| TW201707725A (zh) | 2015-08-18 | 2017-03-01 | 美國馬友醫藥教育研究基金會 | 載體－抗體組合物及其製造及使用方法 |
| TW201713360A (en) | 2015-10-06 | 2017-04-16 | Mayo Foundation | Methods of treating cancer using compositions of antibodies and carrier proteins |
| WO2017120501A1 (en) | 2016-01-07 | 2017-07-13 | Mayo Foundation For Medical Education And Research | Methods of treating cancer with interferon |
| CN105606824B (zh) * | 2016-01-28 | 2018-04-06 | 山东省药物研究院 | 晚期乳腺癌患者外周血循环肿瘤细胞Her‑2基因的检测方法 |
| WO2017139698A1 (en) | 2016-02-12 | 2017-08-17 | Mayo Foundation For Medical Education And Research | Hematologic cancer treatments |
| US11305020B2 (en) | 2016-03-21 | 2022-04-19 | Mayo Foundation For Medical Education And Research | Methods for reducing toxicity of a chemotherapeutic drug |
| EP3432928A4 (en) | 2016-03-21 | 2019-11-20 | Mayo Foundation for Medical Education and Research | PROCESS FOR IMPROVING THE THERAPEUTIC INDEX FOR CHEMOTHERAPEUTIC |
| US10618969B2 (en) | 2016-04-06 | 2020-04-14 | Mayo Foundation For Medical Education And Research | Carrier-binding agent compositions and methods of making and using the same |
| CN109890419A (zh) | 2016-09-01 | 2019-06-14 | 梅约医学教育与研究基金会 | 用于治疗癌症的载体-pd-l1结合剂组合物 |
| CA3035377A1 (en) | 2016-09-01 | 2018-03-08 | Mayo Foundation For Medical Education And Research | Nanoparticle compositions for targeting t-cell cancers |
| WO2018048816A1 (en) | 2016-09-06 | 2018-03-15 | Mayo Foundation For Medical Education And Research | Methods of treating pd-l1 expressing cancer |
| US11590098B2 (en) | 2016-09-06 | 2023-02-28 | Mayo Foundation For Medical Education And Research | Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins |
| EP3509643A1 (en) | 2016-09-06 | 2019-07-17 | Mayo Foundation for Medical Education and Research | Paclitaxel-albumin-binding agent compositions and methods for using and making the same |
| BR112019006329A2 (pt) * | 2016-10-07 | 2019-06-25 | Abraxis Bioscience Llc | métodos de tratamento de câncer do trato biliar |
| WO2018169811A1 (en) | 2017-03-11 | 2018-09-20 | Selecta Biosciences, Inc. | Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant |
| KR20250057947A (ko) | 2017-10-03 | 2025-04-29 | 크리티테크, 인크. | 암의 치료를 위한 면역치료제의 전신 전달과 조합된 항신생물성 입자의 국소 전달 |
| IL277402B1 (en) | 2018-03-20 | 2026-04-01 | Abraxis Bioscience Llc | Methods for treating central nervous system disorders using administration of MTOR inhibitor nanoparticles and albumin |
| CN108498529A (zh) * | 2018-06-20 | 2018-09-07 | 福建师范大学 | 用于肿瘤预防治疗的DNA甲基转移酶抑制剂与cGAMP药物组合物 |
| US20220008383A1 (en) * | 2018-11-13 | 2022-01-13 | Amy Yee | Compositions and methods of enhancing immunotherapies |
| WO2020243745A1 (en) | 2019-05-29 | 2020-12-03 | Nelum Corporation | Methods and uses for treating cancer |
| CN114207440A (zh) | 2019-06-04 | 2022-03-18 | 西莱克塔生物科技公司 | 聚乙二醇化尿酸酶的制剂和剂量 |
| JP7832108B2 (ja) | 2019-10-28 | 2026-03-17 | アブラクシス バイオサイエンス， エルエルシー | アルブミンおよびラパマイシンの医薬組成物 |
| EP4196106A1 (en) * | 2020-08-11 | 2023-06-21 | Auxilla Pharmaceuticals and Research LLP | A non-aqueous suspension of anticancer agent |
| TR202018770A2 (tr) * | 2020-11-23 | 2021-02-22 | Ankara Ueniversitesi | Platine Dirençli Over Kanseri Tedavisine Yönelik Yeni Bir İlaç Taşıyıcı Sistem |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US6096331A (en) | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
| US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
| US6749868B1 (en) | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| BRPI9810945B8 (pt) * | 1997-06-27 | 2021-05-25 | Abraxis Bioscience Inc | formulações de agentes farmacológicos, métodos para sua preparação e métodos para uso das mesmas |
| US6613753B2 (en) * | 2001-02-21 | 2003-09-02 | Supergen, Inc. | Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation |
| CN103405405A (zh) * | 2002-12-09 | 2013-11-27 | 阿布拉西斯生物科学有限责任公司 | 组合物和传递药剂的方法 |
| US7951780B2 (en) * | 2004-02-25 | 2011-05-31 | Astellas Pharma Inc. | Antitumor agent |
| US20050187148A1 (en) * | 2004-02-25 | 2005-08-25 | Yoshinori Naoe | Antitumor agent |
| AU2006249235B2 (en) * | 2004-05-14 | 2010-11-11 | Abraxis Bioscience, Llc | Sparc and methods of use thereof |
| US20060069060A1 (en) * | 2004-09-27 | 2006-03-30 | Sanjeev Redkar | Salts of decitabine |
| NZ589276A (en) * | 2005-02-03 | 2012-06-29 | Topotarget Uk Ltd | Combination therapies using hdac inhibitors and erlotinib (tarceva) |
| US8735394B2 (en) * | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| US20070166388A1 (en) | 2005-02-18 | 2007-07-19 | Desai Neil P | Combinations and modes of administration of therapeutic agents and combination therapy |
| SI1853250T1 (sl) * | 2005-02-18 | 2012-01-31 | Abraxis Bioscience Llc | Kombinacije in reĹľimi dajanja terapevtskih sredstev in kombinirana terapija |
| AU2006284657B2 (en) * | 2005-08-31 | 2012-07-19 | Abraxis Bioscience, Llc | Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| CA2626679C (en) * | 2005-11-04 | 2011-08-16 | Merck & Co., Inc. | Methods of treating cancers with saha, carboplatin, and paclitaxel and other combination therapies |
| US20080057086A1 (en) * | 2006-09-01 | 2008-03-06 | Pharmion Corporation | Colon-targeted oral formulations of cytidine analogs |
| MY148893A (en) * | 2006-12-04 | 2013-06-14 | Novartis Ag | Combination of an hdac inhibitor and an antimetabolite |
| US20100166869A1 (en) | 2007-05-03 | 2010-07-01 | Desai Neil P | Methods and compositions for treating pulmonary hypertension |
| NZ588668A (en) * | 2008-04-03 | 2013-01-25 | Cognate 3 | Uses of helicin and other glucopyranosyloxy benzaldehydes in the treatment of cancer |
| JP2011517683A (ja) | 2008-04-10 | 2011-06-16 | アブラクシス バイオサイエンス， エルエルシー | 疎水性タキサン誘導体の組成物およびその使用 |
| MX2010011165A (es) | 2008-04-10 | 2011-02-22 | Abraxis Bioscience Llc | Composiciones de derivados de taxano hidrofobos y sus usos. |
| EP3782612B1 (en) * | 2008-05-15 | 2023-11-08 | Celgene Corporation | Oral formulations of cytidine analogs and methods of use thereof |
| US20100055047A1 (en) * | 2008-08-26 | 2010-03-04 | Yiyu Zou | Methods for treating bronchial premalignancy and lung cancer |
| NZ593343A (en) * | 2008-12-11 | 2013-04-26 | Abraxis Bioscience Llc | Combination cancer treatment conprising Abraxane and an inflamatory inhibitor |
| PL2470173T3 (pl) * | 2009-08-25 | 2016-11-30 | Leczenie skojarzone nanocząstkowymi kompozycjami taksanu i inhibitorów hedgehog | |
| KR20130028727A (ko) * | 2010-03-29 | 2013-03-19 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 약물 전달 및 유효성 향상 방법 |
| NZ717490A (en) * | 2010-03-29 | 2017-12-22 | Abraxis Bioscience Llc | Methods of treating cancer |
| WO2011153009A1 (en) * | 2010-06-02 | 2011-12-08 | Abraxis Bioscience, Llc | Methods of treating bladder cancer |
| BR112012030909A2 (pt) * | 2010-06-04 | 2020-08-18 | Abraxis Bioscience, Llc | métodos de tratamento de câncer pancreático |
| WO2011156119A1 (en) * | 2010-06-07 | 2011-12-15 | Abraxis Bioscience, Llc | Combination therapy methods for treating proliferative diseases |
| US9149455B2 (en) * | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
| US9511046B2 (en) * | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
-
2011
- 2011-05-20 WO PCT/US2011/037450 patent/WO2011156119A1/en not_active Ceased
- 2011-05-20 AU AU2011264590A patent/AU2011264590B2/en active Active
- 2011-05-20 MY MYPI2012005255A patent/MY166014A/en unknown
- 2011-05-20 CN CN201180038243.9A patent/CN103037846B/zh active Active
- 2011-05-20 RU RU2012156903/15A patent/RU2577278C2/ru active
- 2011-05-20 NZ NZ707377A patent/NZ707377A/en unknown
- 2011-05-20 MX MX2012014231A patent/MX2012014231A/es unknown
- 2011-05-20 RU RU2016103126A patent/RU2016103126A/ru not_active Application Discontinuation
- 2011-05-20 BR BR112012031163A patent/BR112012031163A2/pt not_active Application Discontinuation
- 2011-05-20 PH PH1/2012/502399A patent/PH12012502399A1/en unknown
- 2011-05-20 SG SG10201504590WA patent/SG10201504590WA/en unknown
- 2011-05-20 EP EP11792867.1A patent/EP2575774A4/en not_active Withdrawn
- 2011-05-20 CN CN201610059985.4A patent/CN105832703A/zh active Pending
- 2011-05-20 EP EP16153625.5A patent/EP3056201A1/en not_active Withdrawn
- 2011-05-20 JP JP2013514194A patent/JP6031437B2/ja active Active
- 2011-05-20 KR KR1020137000228A patent/KR101850566B1/ko active Active
- 2011-05-20 US US13/701,001 patent/US20140155344A1/en not_active Abandoned
- 2011-05-20 SG SG2012088001A patent/SG185798A1/en unknown
- 2011-05-20 CA CA2801891A patent/CA2801891C/en active Active
-
2012
- 2012-11-22 IL IL223190A patent/IL223190A0/en unknown
- 2012-11-22 ZA ZA2012/08820A patent/ZA201208820B/en unknown
- 2012-12-06 NI NI201200181A patent/NI201200181A/es unknown
- 2012-12-14 CR CR20120638A patent/CR20120638A/es unknown
-
2013
- 2013-01-04 CO CO13001846A patent/CO6670568A2/es unknown
- 2013-03-01 US US13/782,992 patent/US20140170228A1/en not_active Abandoned
-
2016
- 2016-07-04 JP JP2016132221A patent/JP2016175947A/ja not_active Withdrawn
- 2016-11-28 US US15/361,851 patent/US20170181998A1/en not_active Abandoned
-
2017
- 2017-03-15 AU AU2017201757A patent/AU2017201757A1/en not_active Abandoned
-
2018
- 2018-02-16 JP JP2018025928A patent/JP2018087227A/ja active Pending
- 2018-08-10 US US16/101,027 patent/US20190167629A1/en not_active Abandoned
-
2019
- 2019-10-03 IL IL26980819A patent/IL269808A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013533232A5 (https=) | ||
| JP2013527232A5 (https=) | ||
| RU2012156903A (ru) | Способы комбинированной терапии для лечения пролиферативных заболеваний | |
| Sun et al. | Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system | |
| Socinski et al. | Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer | |
| JP2011079858A5 (https=) | ||
| Socinski et al. | Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer | |
| NZ708506A (en) | Methods of treating bladder cancer | |
| JP2013503174A5 (https=) | ||
| JP2012520323A5 (https=) | ||
| Wang et al. | Gold nanoparticle-mediated delivery of paclitaxel and nucleic acids for cancer therapy | |
| JP2016536352A5 (https=) | ||
| MX369728B (es) | Métodos para mejorar suministro de fármacos y efectividad de agentes terapéuticos. | |
| JP2015516989A5 (https=) | ||
| JP2008530248A5 (https=) | ||
| JP2010209081A5 (https=) | ||
| HRP20160609T1 (hr) | Postupci liječenja hepatocelularnog karcinoma | |
| JP2015524444A5 (https=) | ||
| RU2017132877A (ru) | Комбинация антагониста pd-1 и эрибулина для лечения рака | |
| JP2009515901A5 (https=) | ||
| JP2019530706A5 (https=) | ||
| CN107073015B (zh) | 用于治疗吸烟者中的非小细胞肺癌的维利帕尼与卡铂和紫杉醇的组合 | |
| JP2015510945A5 (https=) | ||
| JP2013541582A5 (https=) | ||
| JP2011500650A5 (https=) |